
GlycoMimetics, Inc. (GLYC) Dividend History
GlycoMimetics, Inc. (GLYC) is a biopharmaceutical company focused on developing innovative glycomimetic drugs to treat cancers, infectious diseases, and inflammatory conditions. The company's research emphasizes targeting selectin proteins and other carbohydrate-mediated pathways to improve patient outcomes.
9708 Medical Center Drive, Rockville, MD, 20850
Phone: 240-243-1201
Website: https://www.glycomimetics.com
Phone: 240-243-1201
Website: https://www.glycomimetics.com
Dividend History
GlycoMimetics, Inc. currently does not pay dividends
Company News
-
GlobeNewswire Inc.